Trial Identifier: | 15993 |
Sponsor: | AstraZeneca |
Collaborator: |
Eli Lilly and Company
|
NCTID:: | NCT03222427 |
Start Date: | January 2018 |
Primary Completion Date: | February 2018 |
Study Completion Date: | February 2018 |
Condition: | Healthy Volunteers |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
United Kingdom, West Yorkshire | Leeds, West Yorkshire, United Kingdom |